Business Context and Reporting Period
This Form 8-K is filed by Second Sight Medical Products, Inc. (not Vivani Medical, Inc.) on April 30, 2020. The registrant is an emerging growth company incorporated in California, with common stock (EYES) and warrants (EYESW) trading on the Nasdaq.
Key Financial Metrics
The filing does not report revenue, profit, cash flow, margins, or debt levels. The primary financial event disclosed is a capital raise:
- Offering Size: 7,500,000 shares of common stock.
- Offering Price: $1.00 per share.
- Gross Proceeds: $7,500,000 (prior to underwriting discounts and expenses).
- Expected Closing Date: May 5, 2020.
Material Changes
The filing announces a material change in the company's capital structure through an underwritten public offering. No comparative financial data or changes in operating metrics versus prior periods are provided in this specific report.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operations, or specific risk factors beyond the standard closing conditions for the offering. The transaction is subject to the satisfaction of customary closing conditions.
Investor Verification Checklist
- Verify the final closing date of the offering (expected May 5, 2020).
- Confirm the net proceeds after deducting underwriting discounts and offering expenses.
- Review the attached press release (Exhibit 99.1) for details on the use of proceeds.
- Check subsequent filings for the actual closing of the transaction and updated share count.